Cargando…

A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients

Tildrakizumab is a humanized IgG1κ monoclonal antibody that selectively targets the p19 subunit of interleukin IL-23, thereby inhibiting the IL-23/IL-17 axis, which is primarily implicated in the immunopathogenesis of psoriasis. Tildrakizumab is approved for the treatment of moderate-to-severe plaqu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campione, Elena, Lambiase, Sara, Gaeta Shumak, Ruslana, Galluzzo, Marco, Lanna, Caterina, Costanza, Gaetana, Borselli, Cristiana, Artosi, Fabio, Cosio, Terenzio, Tofani, Lorenzo, Dattola, Annunziata, Di Daniele, Francesca, Bianchi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141711/ https://www.ncbi.nlm.nih.gov/pubmed/37111283 http://dx.doi.org/10.3390/ph16040526

Ejemplares similares

Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
por: Galluzzo, Marco, et al.
Publicado: (2022)

Tildrakizumab in moderate‐to‐severe plaque psoriasis: A multicenter, retrospective, real‐life study
por: Caldarola, Giacomo, et al.
Publicado: (2022)

The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway
por: Campione, Elena, et al.
Publicado: (2022)

Experimental Pharmacological Management of Psoriasis
por: Campione, Elena, et al.
Publicado: (2021)

From In Silico Simulation between TGF-β Receptors and Quercetin to Clinical Insight of a Medical Device Containing Allium cepa: Its Efficacy and Tolerability on Post-Surgical Scars
por: Cosio, Terenzio, et al.
Publicado: (2023)

Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes
por: Caputo, Valerio, et al.
Publicado: (2020)

Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss and Optical Coherence Tomography Assessments
por: Ardigò, Marco, et al.
Publicado: (2020)

Usefulness of Topical Imiquimod 3.75% in Cytokeratin 7 Positive Extramammary Paget Disease of the Vulva: Towards Personalized Therapy
por: Mazzilli, Sara, et al.
Publicado: (2021)

A Case of Pincer Nail Successfully Treated with Tazarotene 0.1% Gel
por: Vollono, Laura, et al.
Publicado: (2020)

Tildrakizumab: Successful Response in Two Patients With Psoriatic Arthritis
por: Buononato, Dario, et al.
Publicado: (2022)

Retinoids in Fungal Infections: From Bench to Bedside
por: Cosio, Terenzio, et al.
Publicado: (2021)

Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
por: Campione, Elena, et al.
Publicado: (2020)

Lichenoid Keratosis: A Clinical Trap without Secrets for Reflectance Confocal Microscopy
por: Mazzilli, Sara, et al.
Publicado: (2020)

The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
por: Campione, Elena, et al.
Publicado: (2019)

Trifarotene: A Current Review and Perspectives in Dermatology
por: Cosio, Terenzio, et al.
Publicado: (2021)

Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations
por: Iacovelli, Federico, et al.
Publicado: (2022)

Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021)

Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
por: Talamonti, M., et al.
Publicado: (2020)

Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

Patidegib in Dermatology: A Current Review
por: Cosio, Terenzio, et al.
Publicado: (2021)

The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis
por: Fukasawa, Takemichi, et al.
Publicado: (2023)

Mepolizumab induced palmoplantar psoriasis: A case report
por: Artosi, Fabio, et al.
Publicado: (2023)

HLA‐C*06:02 allele can influence clinical efficacy of certolizumab pegol?
por: Dattola, Annunziata, et al.
Publicado: (2021)

Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide: A Proof of Concept for Combined Treatments with Hedgehog Inhibitors in Advanced Basal Cell Carcinoma
por: Cosio, Terenzio, et al.
Publicado: (2020)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Tildrakizumab in the treatment of psoriasis – literature review
por: Banaszczyk, Katarzyna
Publicado: (2019)

Tildrakizumab ineffective in generalized granuloma annulare
por: Song, Eingun James
Publicado: (2020)

MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy
por: Rapanotti, Maria Cristina, et al.
Publicado: (2021)

Sofosbuvir induced leucocytoclasic vasculitis: a case report
por: Campione, Elena, et al.
Publicado: (2019)

Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy
por: Pithadia, Deeti J., et al.
Publicado: (2019)

Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab
por: Kimball, A.B., et al.
Publicado: (2019)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

Pyodermitis during Nivolumab Treatment for Non-Small Cell Lung Cancer: A Case Report and Review of the Literature
por: Cosio, Terenzio, et al.
Publicado: (2023)

Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
por: Lanna, Caterina, et al.
Publicado: (2019)

Prevalence of Atherosclerosis in Psoriatic Patients Detected with Epiaortic Color Doppler Ultrasound and Computed Tomography Angiography
por: Dattola, Annunziata, et al.
Publicado: (2022)

Dermoscopy and Reflectance Confocal Microscopy in the Diagnosis and Management of Nail Fold Squamous Cell Carcinoma
por: Mazzilli, Sara, et al.
Publicado: (2020)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
por: Mease, Philip J, et al.
Publicado: (2021)

Effective and Safe Treatment of Psoriatic Disease with the Anti-IL-23p19 Biologic Tildrakizumab: Results of a Real-World Prospective Cohort Study in Nonselected Patients
por: Drerup, Katharina A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2uknl1f4tif9rvovi1etf4feq